4-(pyrid-2-yl) amino substituted pyrimidine as protein kinase inhibitors

Details for Australian Patent Application No. 2006235676 (hide)

Owner AstraZeneca AB

Inventors Nowak, Thorsten; Thomas, Andrew Peter

Agent Davies Collison Cave

Pub. Number AU-A-2006235676

PCT Pub. Number WO2006/109026

Priority 0507347.3 12.04.05 GB

Filing date 7 April 2006

Wipo publication date 19 October 2006

International Classifications

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/4427 (2006.01) - containing further heterocyclic ring systems

A61P 35/00 (2006.01) Antineoplastic agents

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2006/109026 Priority application(s): WO2006/109026

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006235678-A pesticide and repellant

2006235674-Wave energy apparatus